learning

Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCOActuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO

Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO

Phase 2 highlights robust biomarker identification and survival correlations in first-line metastatic pancreatic cancer (mPDAC) treated with elraglusib June 20,…

2 hours ago
AMITY SCHOOL OF FASHION TECHNOLOGY SHOWCASES AT DELHI TIMES FASHION WEEK 2025AMITY SCHOOL OF FASHION TECHNOLOGY SHOWCASES AT DELHI TIMES FASHION WEEK 2025

AMITY SCHOOL OF FASHION TECHNOLOGY SHOWCASES AT DELHI TIMES FASHION WEEK 2025

DELHI, May 29, 2025 /PRNewswire/ -- Students from Amity School of Fashion Technology participated in the prestigious Delhi Times Fashion…

2 weeks ago